Figures
1.5Healthcare financing structures in China and India in 2013
1.13Population with access to improved sanitation facilities, 1990–2012
1.14Population with access to improved water sources, 1990–2012
1.19Human Development Index, 2012, and change from 1992 to 2012
1.21Annual per capita growth of GDP and total health expenditures (THE)
3.1Disparity and diversity in life expectancy and per capita GDP across China’s provinces, 2010
3.2Decline in maternal mortality rate (MMR): urban versus rural areas
3.4The incidence rate of infectious diseases (categories A and B)
3.5The mortality rate of infectious diseases (categories A and B)
3.7Number of infectious disease cases by transmission routes in China, 1990–2013
3.8Annual reported HIV-positive and AIDS cases by transmission source, 1985–2013
3.11Prevalence of NCD risk factors in adults aged >18 in 2010
3.13Trend of cancer age-standardized incidence and mortality rate, 1998–2011
3.14Economic burden of NCDs: comparison of average hospital cost and household income, 2012
3.18National Center for Non-communicable Diseases Control organizational structure
4.1Change in number of deaths of five major chronic diseases, 1990 and 2010
4.2Change in age-standardized mortality rates of five major chronic diseases, 1990 and 2010
4.3Total number of community and township health centers, 2002–2011
5.4Early success with DRGs in Beijing Class III hospital pilots
6.1Health spending on NCDs in China, by type of service, 2013
8.5Growth of hospital admissions by ownership (Unit: 10,000), 2005–2013
8.6Growth of outpatient visits by ownership (Unit: 10,000), 2005–2013
8.7Dispersion of power among ministries and public hospitals
8.10Organizational, autonomy, and accountability characteristics of selected public hospital governance reform models, 2015
8.11Categories and indicators used for performance appraisal and bonuses
10.1Age structure of China’s population in 1950, 2010, and 2050 (projected)
11.1Coverage, reimbursement, and fund surplus of UEBMI, URBMI, and NCMS
11.2Government and out-of-pocket spending on health as a percent of total health expenditures in select countries, 2012
11.5Private health insurance as percent of total health expenditures of select countries, 2012
15.2Growth in China’s medical device and pharmaceutical markets
15.5Tiered medical system, public hospital reform, and private hospitals
15.6Reform impact on hospital revenue from medical services and diagnostic procedures
15.7NHFPC pilot program with 500 county hospitals, January 2015
15.8Growth of private hospitals and demand for middle/high-end medical devices
15.9Growth of capital equipment and reagent/consumable funding
15.10Drivers of sustainable development of medical device sector
15.22Government bureaus influencing medical device market access
15.23Key concerns in regulatory environment for multinationals
15.26Pricing liberalization and decentralization in drug procurement
15.27Government pricing regulation and centralized procurement
15.36Growth of mid-market Class IIA hospitals in tier 2/3 cities
15.39Lack of medtech training programs in Chinese universities
16.1Government and industry roles in research and development
16.4Compound annual growth rate of biomedical R&D expenditures by country, adjusted for inflation, 2007–2012
